perfluorooctane sulfonic acid has been researched along with Non-alcoholic Fatty Liver Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 5 (83.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dunder, L; Elmståhl, S; Lind, L; Lind, PM; Salihovic, S | 1 |
| An, H; Ao, L; Cao, J; Chen, Q; Cui, H; He, S; Ling, X; Liu, J; Wang, L; Yang, W; Yang, Z; Zou, P | 1 |
| Akhlaghi, F; Auclair, A; Barlock, BJ; Goedken, M; Jamwal, R; Marques, E; Pfohl, M; Sammoura, FM; Slitt, AL | 1 |
| Baldwin, WS; Ford, L; Hamilton, MC; Heintz, MM; Marques, E; Pfohl, M; Slitt, AL | 1 |
| Marques, E; Nahar, PP; Salter, DM; Slitt, AL; Wei, W | 1 |
| Bagley, BD; Butenhoff, JL; Chang, SC; Ehresman, DJ; Eveland, A; Parker, GA; Peters, JM; Wallace, KB; Zitzow, JD | 1 |
6 other study(ies) available for perfluorooctane sulfonic acid and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Associations between per- and polyfluoroalkyl substances (PFAS) and diabetes in two population-based cohort studies from Sweden.
Topics: Alkanesulfonic Acids; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Environmental Pollutants; Female; Fluorocarbons; Glucose; Humans; Longitudinal Studies; Male; Non-alcoholic Fatty Liver Disease; Obesity; Sweden | 2023 |
PPARα/ACOX1 as a novel target for hepatic lipid metabolism disorders induced by per- and polyfluoroalkyl substances: An integrated approach.
Topics: Alkanesulfonic Acids; Animals; Caprylates; Chemical and Drug Induced Liver Injury; Cross-Sectional Studies; Environmental Pollutants; Fluorocarbons; Humans; Lipid Metabolism; Lipid Metabolism Disorders; Mice; Non-alcoholic Fatty Liver Disease; Nutrition Surveys; PPAR alpha; Rats | 2023 |
Perfluorooctanesulfonic acid (PFOS) administration shifts the hepatic proteome and augments dietary outcomes related to hepatic steatosis in mice.
Topics: Alkanesulfonic Acids; Animals; Diet, High-Fat; Fluorocarbons; Lipid Metabolism; Liver; Male; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Proteome | 2020 |
Increased toxicity and retention of perflourooctane sulfonate (PFOS) in humanized CYP2B6-Transgenic mice compared to Cyp2b-null mice is relieved by a high-fat diet (HFD).
Topics: Alkanesulfonic Acids; Animals; Cytochrome P-450 CYP2B6; Diet, High-Fat; Female; Fluorocarbons; Gene Expression; Humans; Liver; Male; Mice, Transgenic; Non-alcoholic Fatty Liver Disease; Triglycerides | 2021 |
Perfluorooctanesulfonic Acid (PFOS) Thwarts the Beneficial Effects of Calorie Restriction and Metformin.
Topics: Alkanesulfonic Acids; AMP-Activated Protein Kinases; Animals; Caloric Restriction; Fluorocarbons; Liver; Male; Metformin; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease | 2021 |
Perfluorooctane Sulfonate-Induced Hepatic Steatosis in Male Sprague Dawley Rats Is Not Attenuated by Dietary Choline Supplementation.
Topics: Alkanesulfonic Acids; Animals; Biomarkers; Cholesterol; Choline; Dietary Supplements; Environmental Pollutants; Fatty Acids, Nonesterified; Female; Fluorocarbons; Gene Expression Regulation; Liver; Male; Non-alcoholic Fatty Liver Disease; Organ Size; Rats, Sprague-Dawley; RNA, Messenger; Sex Factors; Time Factors; Triglycerides | 2017 |